3-methoxytyramine has been researched along with Genetic Predisposition in 1 studies
3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klejbor, I | 1 |
| Myers, JM | 1 |
| Hausknecht, K | 1 |
| Corso, TD | 1 |
| Gambino, AS | 1 |
| Morys, J | 1 |
| Maher, PA | 1 |
| Hard, R | 1 |
| Richards, J | 1 |
| Stachowiak, EK | 1 |
| Stachowiak, MK | 1 |
1 other study available for 3-methoxytyramine and Genetic Predisposition
| Article | Year |
|---|---|
Fibroblast growth factor receptor signaling affects development and function of dopamine neurons - inhibition results in a schizophrenia-like syndrome in transgenic mice.
Topics: Animals; Cell Differentiation; Cell Enlargement; Disease Models, Animal; Dopamine; Dopamine Plasma M | 2006 |